HR-747 : Still Just a Bill

The Stop Chinese Fentanyl Act of 2025, also known as H.R. 747, aims to combat the flow of synthetic opioids, particularly fentanyl, from China into the United States. Key provisions include:

• Expressing the sense of Congress that the People's Republic of China should collaborate with the U.S. to regulate chemicals used in the production of precursor chemicals, enforce proper labeling of chemical shipments, implement "know-your-customer" procedures, and crack down on precursor trafficking.
• Amending the Fentanyl Sanctions Act to broaden the definition of "foreign opioid trafficker" to include Chinese entities and officials involved in the production, distribution, or financing of goods related to opioid trafficking, especially those who fail to take credible steps to prevent it.
• Requiring the President to periodically evaluate the effectiveness of sanctions imposed under the International Emergency Economic Powers Act related to international drug trafficking.
• Mandating the President to consider costs and benefits of regulations and establish criteria for terminating national emergencies related to international drug trafficking.
• Clarifying that the Act does not authorize sanctions on the importation of goods.

In summary, the Act seeks to hold Chinese entities and officials accountable for their role in the fentanyl crisis by imposing sanctions and encouraging greater cooperation between the U.S. and China in combating opioid trafficking.